Form D · Other Health Care

AVAVA, Inc.

Waltham, MA · CIK 0001696341

Offering snapshot reported Mar 4, 2026 · SEC filing

Reported sold
$19.6M
Offering amount: $38M
Investors reported
59
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 17, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 4, 2026Initial$19,612,101No comparison59SEC filing
Apr 19, 2024Initial$25,203,932No comparison41SEC filing
Jan 30, 2017Initial$4,000,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-575437
The total amount sold includes $19,612,101 of the Company's existing Series D preferred stock that converted to common stock and were exchanged for shares of Series AA preferred stock of the same value.

Source: Form D, filed Mar 4, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard Rox Anderson Director
Jay Bhawalkar Executive
Daniel Browne Director
Dan Browne Director
Clinton Earl Carnell Jr. Director, Executive
Henry Hin Lee Chan Director
Craig A. Drill Director
Irina Erenburg Director, Executive
Mary Fisher Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
275 Second Avenue Floor 3
Waltham, MA, 02451